The photo-activating chemical includes an antibody that combines tumor cells (EGFR antibody in head and neck cancers) and a photo-absorbing dye, and the absorption of the NIR light induces a ligand-release reaction and even an antitumor immune reaction [115, 116]. This evidence concerns the gene EGFR and head and neck cancer.